{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:21:58Z","timestamp":1771467718101,"version":"3.50.1"},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T00:00:00Z","timestamp":1153180800000},"content-version":"vor","delay-in-days":4400,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Head &amp; Neck"],"published-print":{"date-parts":[[1994,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Background.<\/jats:italic> One of the dose\u2010limiting adverse effects of chemoradiotherapy is mucositis, especially oral mucositis. Prophylaxis of severe mucosal reaction would allow application of aggressive chemoradiotherapy to malignancies.<\/jats:p><jats:p><jats:italic>Methods.<\/jats:italic> Sixty\u2010three patients who received inductive concomitant chemoradiotherapy with cobalt 60 (<jats:sup>60<\/jats:sup>Co<jats:sub>1<\/jats:sub> \u223c 30 Gy), peplomycin (PLM, \u223c 38 mg), and 5\u2010fluorouracil (5\u2010FU, \u223c3,500 mg) were included in this study. From the start of therapy to the disappearance of oral erosion, 37 patients received daily doses of Azelastine (2 mg) + vitamin C (500 mg) + vitamin E (200) + glutathione (200 mg) (azelastine group), whereas the other 26 patients received the same regimen without azelastine (control group). The severity of oral mucositis in both groups was evaluated periodically.<\/jats:p><jats:p><jats:italic>Results<\/jats:italic>. At 10 Gy with 15 mg PLM and 1,250 mg 5\u2010FU, grade 1 mucositis (redness of the oral mucosa) was induced in 14 patients in the control group and five patients in the Azelastine group. At 20 Gy with 30 mg PLM and 2,500 mg 5\u2010FU, grade 2 (erosion with mild irritation) and grade 3 (extensive erosion with marked irritation) stomatitis were observed in 9 and 3 of the control patients and 5 and 1 in the Azelastine group, respectively. At the completion of treatment, mucositis in 21 patients in the Azelastine group remained at grade 1 or grade 2, whereas grades 3 and 4 (ulceration with severe contact pain) mucositis were observed in 6 and 10 patients, respectively. However, in the control group, grades 1 and 2 were observed in only 2 and 3 cases, whereas grades 3 and 4 stomatitis were induced in 6 and 15, respectively. Azelastine suppressed neutrophil respiratory burst both in vivo and in vitro, and also suppressed cytokine release from lymphocytes. However, neutrophil superoxide dismutase (SOD) activity was negligibly suppressed.<\/jats:p><jats:p><jats:italic>Conclusion.<\/jats:italic> A regimen including Azelastine, which suppresses reactive oxygen production and stabilizes cell membranes, may be useful for the prophylaxis of mucositis due to chemoradiotherapy. \u00a9 1994 John Wiley &amp; Sons, Inc.<\/jats:p>","DOI":"10.1002\/hed.2880160407","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T22:08:20Z","timestamp":1172095700000},"page":"331-339","source":"Crossref","is-referenced-by-count":41,"title":["Prophylaxis of oral mucositis associated with chemoradiotherapy for oral carcinoma by Azelastine hydrochloride (Azelastine) with other antioxidants"],"prefix":"10.1002","volume":"16","author":[{"given":"Tokio","family":"Osaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisaku","family":"Ueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jusui","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,18]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.1977.11712115"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1200\/JCO.1986.4.7.1058","article-title":"High\u2010dose continuous infusion folinic acid and bolus 5\u2010fluorouracil in patients with advanced colorectal cancer: a phase II study","volume":"4","author":"Bertrand M","year":"1986","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1200\/JCO.1991.9.4.625","article-title":"A phase II study of weekly 24\u2010hour infusion with high\u2010dose fluorouracil with leucovorin in colorectal carcinoma","volume":"9","author":"Aradlan B","year":"1991","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(90)90050-4"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19901215)66:12<2470::AID-CNCR2820661205>3.0.CO;2-Y"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198937040-00007"},{"key":"e_1_2_1_8_2","first-page":"48","article-title":"Bleomycin increases superoxide anion generation by pig peripheral alveolar macrophages","volume":"30","author":"Conley NS","year":"1986","journal-title":"Mol Pharmacol"},{"key":"e_1_2_1_9_2","first-page":"291","article-title":"Enhancing effect of bleomycin and its analog on free radical generation","volume":"40","author":"Kimura H","year":"1991","journal-title":"J Jpn Stomatol Soc"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/09553008214550471"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(92)90550-9"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900415)65:8<1879::AID-CNCR2820650834>3.0.CO;2-8"},{"key":"e_1_2_1_13_2","first-page":"267","article-title":"Allopurinol mouthwash and 5\u2010fluorouracil induced oral toxicity","volume":"11","author":"Clark PI","year":"1985","journal-title":"Eur J Surg Oncol"},{"key":"e_1_2_1_14_2","first-page":"405","article-title":"Reduction of oral toxicity of 5\u2010fluorouracil by allopurinol mouthwashes","volume":"14","author":"Tsavaris N","year":"1988","journal-title":"Eur J Surg Oncol"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90451-7"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb1978.12.37"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(89)90125-5"},{"key":"e_1_2_1_18_2","first-page":"767","article-title":"Inhibitory effects of azelastine on superoxide anion generation from activated inflammatory cells measured by a simple chemiluminescence method","volume":"40","author":"Kurosawa M","year":"1990","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108615"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(84)90467-6"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.9.1591"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198712000-00015"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00296969"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(79)91843-6"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(89)90442-5"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.2307\/3573804"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(84)81232-6"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1016\/S0021-9258(18)32488-8","article-title":"A study of the reactivity of HO2\/ O2\u2010 with unsaturated fatty acids","volume":"258","author":"Bielski BH","year":"1983","journal-title":"J Biol Chem"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)89536-9"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nu.05.070185.001543"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)43026-2"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90311-4"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01982866"},{"key":"e_1_2_1_34_2","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1128\/iai.57.7.2115-2122.1989","article-title":"Tumor necrosis factor alpha potentiates neutrophils antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release","volume":"57","author":"Ferrante A","year":"1989","journal-title":"Infect Immun"},{"key":"e_1_2_1_35_2","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1182\/blood.V77.10.2259.2259","article-title":"Production of granulocyte\u2010macrophage colony\u2010stimulating factor by large granular lymphocytes stimulated with Candida albicans: role in activation of human neutrophil function","volume":"77","author":"Blanchard DK","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(89)81718-1"},{"key":"e_1_2_1_37_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4049\/jimmunol.149.1.331","article-title":"Immune complex\u2010induced lung and dermal vascular injury. Differing requirements for tumor necrosis factor\u2010alpha and IL\u20101","volume":"149","author":"Mulligan MS","year":"1992","journal-title":"J Immunol"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02591662"}],"container-title":["Head &amp; Neck"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhed.2880160407","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hed.2880160407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T19:24:50Z","timestamp":1698175490000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hed.2880160407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1994,7]]}},"alternative-id":["10.1002\/hed.2880160407"],"URL":"https:\/\/doi.org\/10.1002\/hed.2880160407","archive":["Portico"],"relation":{},"ISSN":["1043-3074","1097-0347"],"issn-type":[{"value":"1043-3074","type":"print"},{"value":"1097-0347","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,7]]}}}